April 22, 2010 (Meeting 11)
Public Health Agency of Canada
David Butler-Jones, Chief Public Health Officer
Frank Plummer, Chief Science Officer, Scientific Director General, National Microbiology Laboratory
Steven Sternthal, Head, Canadian HIV Vaccine Initiative Secretariat, Director, Office of HIV Vaccines
April 15, 2010 (Meeting 9)
Bill & Melinda Gates Foundation
Stefano Bertozzi, Director, Global Health HIV
Global HIV Vaccine Enterprise
Alan Bernstein, Executive Director
International Centre for Infectious Diseases
Heather Medwick, Acting President and Chief Executive Officer
International Consortium on Anti-Virals
Jeremy Carver, President, Chief Executive Officer and Chief Scientific Officer
Patrick Michaud, Chairman of the Board of Directors
University of Manitoba
Keith Fowke, Professor, Departments of Medical Microbiology and Community Health Sciences
University of Western Ontario
Ted Hewitt, Vice-President, Research and International Relations
April 13, 2010 (Meeting 8)
Canadian Association for HIV Research
Bill Cameron, President
PnuVax Inc.
Donald Gerson, President and Chief Executive Officer
Public Health Agency of Canada
Rainer Engelhardt, Assistant Deputy Minister, Infectious Disease Prevention and Control Branch
Steven Sternthal, Head, Canadian HIV Vaccine Initiative Secretariat, Director, Office of HIV Vaccines
Vaccine and Gene Therapy Institute Florida
Rafick-Pierre Sékaly, Co-Director and Scientific Director